Modeling methods for estimating HIV incidence: a mathematical review.
Estimating HIV incidence is crucial for monitoring the epidemiology of this infection, planning screening and intervention campaigns, and evaluating the effectiveness of control measures. However, owing to the long and variable period from HIV infection to the development of AIDS and the introduction of highly active antiretroviral therapy, accurate incidence estimation remains a major challenge. Numerous estimation methods have been proposed in epidemiological modeling studies, and here we review commonly-used methods for estimation of HIV incidence. We review the essential data required for estimation along with the advantages and disadvantages, mathematical structures and likelihood derivations of these methods. The methods include the classical back-calculation method, the method based on CD4+ T-cell depletion, the use of HIV case reporting data, the use of cohort study data, the use of serial or cross-sectional prevalence data, and biomarker approach. By outlining the mechanistic features of each method, we provide guidance for planning incidence estimation efforts, which may depend on national or regional factors as well as the availability of epidemiological or laboratory datasets.
['Sun|Xiaodan|X|', 'Nishiura|Hiroshi|H|0000-0003-0941-8537', 'Xiao|Yanni|Y|']
D023241:Antiretroviral Therapy, Highly Active D015331:Cohort Studies D003430:Cross-Sectional Studies D015658:HIV Infections D006801:Humans D015994:Incidence D015233:Models, Statistical D015995:Prevalence
CD4 Biomarker HIV/AIDS Mathematical model statistical estimation